The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club
Open accessThe DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Abstract
The exact role of biochemical markers of bone turnover in the management of metabolic bone diseases remains a topic of controversy. In this consensus paper, the Belgian Bone Club aimed to provide a state of the art on the use of these biomarkers in different clinical or physiological situations like in postmenopausal women, osteoporosis in men, in elderly patients, in patients suffering from bone metastasis, in patients with chronic renal failure, in pregnant or lactating women, in intensive care patients, and in diabetics. We also gave our considerations on the analytical issues linked to the use of these biomarkers, on potential new emerging biomarkers, and on the use of bone turnover biomarkers in the follow-up of patients treated with new drugs for osteoporosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, the serum procollagen type I N-terminal propeptide (PINP) has been recommended as a standard marker for bone formation, while the carboxyl-terminal telopeptide of collagen type I (CTXI) has been recommended as a standard marker for bone resorption [68, 93, 95].”
From The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms (2018) · cites this paper as [95]
Citations
Cites
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, J. A., McCloskey, E. V., Johansson, H., Cooper, C., Rizzoli, R., Reginster, J.-Y., & on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) · Osteoporosis International · doi:10.1007/s00198-012-2074-y · Cited by 2,948
Self-citationTjäderhane, L., Buzalaf, M. A. R., Carrilho, M., & Chaussain, C. (2015) · Caries Research · doi:10.1159/000363582 · Cited by 2,306
MacLeod, A. M. (2009) · Kidney International · Cited by 2,219
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753
Meunier, P. J., Roux, C., Seeman, E., Ortolani, S., Badurski, J. E., Spector, T. D., Cannata, J., Balogh, A., Lemmel, E.-M., Pors-Nielsen, S., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa022436 · Cited by 1,638
Self-citationRomosozumab in Postmenopausal Women with Low Bone Mineral Density
McClung, M. R., Grauer, A., Boonen, S., Bolognese, M. A., Brown, J. P., Diez-Perez, A., Langdahl, B. L., Reginster, J.-Y., Zanchetta, J. R., Wasserman, S. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1305224 · Cited by 1,258
Self-citationfor the IOF-IFCC Bone Marker Standards Working Group, Vasikaran, S., Eastell, R., Bruyère, O., Foldes, A. J., Garnero, P., Griesmacher, A., McClung, M., Morris, H. A., Silverman, S., et al. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1501-1 · Cited by 1,212 · cited 5×
“Conflicting results about the association between BTMs and change in BMD or fracture risk may be explained by differences in the study populations and assays for BTMs [3, 43].”
BackgroundResultInfluentialSelf-citationEckardt, K.-U., & Kasiske, B. L. (2009) · Kidney International · doi:10.1038/ki.2009.188 · Cited by 1,167
Denosumab in men receiving androgen-deprivation therapy for prostate cancer
Smith, M. R., Egerdie, B., Toriz, N. H., Feldman, R., Tammela, T. L. J., Saad, F., Heracek, J., Szwedowski, M., Ke, C., Kupic, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809003 · Cited by 1,140
Brunkow, M. E., Gardner, J. C., Van Ness, J., Paeper, B. W., Kovacevich, B. R., Proll, S., Skonier, J. E., Zhao, L., Sabo, P. J., Fu, Y.-H., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318811 · Cited by 1,011 · cited 1×
“bone mass [12].”
van Bezooijen, R. L., Roelen, B. A. J., Visser, A., van der Wee-Pals, L., de Wilt, E., Karperien, M., Hamersma, H., Papapoulos, S. E., ten Dijke, P., & Löwik, C. W. G. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031454 · Cited by 892
Biochemical markers of bone turnover: part I: biochemistry and variability.
Seibel, M. J. (2005) · Europe PMC (PubMed Central) · Cited by 779
Orwoll, E., Scheele, W., Paul, S., Adami, S., Syversen, U., Diez-Perez, A., Kaufman, J.-M., Clancy, A., & Gaich, G. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.1.9 · Cited by 776
Self-citationMolecular and cellular mechanisms of the anabolic effect of intermittent PTH
Jilka, R. L. (2007) · Bone · doi:10.1016/j.bone.2007.03.017 · Cited by 720
Less-Tight versus Tight Control of Hypertension in Pregnancy
Magee, L. A., von Dadelszen, P., Rey, E., Ross, S., Asztalos, E., Murphy, K. E., Menzies, J., Sanchez, J., Singer, J., Gafni, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1404595 · Cited by 672
The Collagenolytic Activity of Cathepsin K Is Unique among Mammalian Proteinases
Garnero, P., Borel, O., Byrjalsen, I., Ferreras, M., Drake, F. H., McQueney, M. S., Foged, N. T., Delmas, P. D., & Delaissé, J.-M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32347 · Cited by 644
Bone health in cancer patients: ESMO Clinical Practice Guidelines
Coleman, R., Body, J. J., Aapro, M., Hadji, P., & Herrstedt, J. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu103 · Cited by 564
Self-citationBrown, J. E., Cook, R. J., Major, P., Lipton, A., Saad, F., Smith, M., Lee, K.-A., Zheng, M., Hei, Y.-J., & Coleman, R. E. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji002 · Cited by 559
Coleman, R. E., Major, P., Lipton, A., Brown, J. E., Lee, K.-A., Smith, M., Saad, F., Zheng, M., Hei, Y. J., Seaman, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.091 · Cited by 533
Saag, K. G., Zanchetta, J. R., Devogelaer, J., Adler, R. A., Eastell, R., See, K., Krege, J. H., Krohn, K., & Warner, M. R. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24879 · Cited by 493 · cited 1×
“The changes observed in BTMs are similar in direction and magnitude to those observed in patients with postmenopausal osteoporosis treated by BPs and teriparatide [50, 57, 58].”
ResultSelf-citationKhosla, S. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.7.2266 · Cited by 447
Tartrate-Resistant Acid Phosphatase 5b: A Novel Serum Marker of Bone Resorption
Halleen, J. M., Alatalo, S. L., Suominen, H., Cheng, S., Janckila, A. J., & Väänänen, H. K. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.7.1337 · Cited by 415
Bone, H. G., McClung, M. R., Roux, C., Recker, R. R., Eisman, J. A., Verbruggen, N., Hustad, C. M., DaSilva, C., Santora, A. C., & Ince, B. A. (2010) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.091035 · Cited by 335
Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation
Lotinun, S., Kiviranta, R., Matsubara, T., Alzate, J. A., Neff, L., Lüth, A., Koskivirta, I., Kleuser, B., Vacher, J., Vuorio, E., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64840 · Cited by 328
Bone turnover markers: use in osteoporosis
Naylor, K., & Eastell, R. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.86 · Cited by 262
Leder, B. Z., O'Dea, L. S. L., Zanchetta, J. R., Kumar, P., Banks, K., McKay, K., Lyttle, C. R., & Hattersley, G. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3718 · Cited by 261
Markers of Bone Turnover Predict Postmenopausal Forearm Bone Loss Over 4 Years: The OFELY Study
Garnero, P., Sornay-Rendu, E., Duboeuf, F., & Delmas, P. D. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.9.1614 · Cited by 256
Orwoll, E., Teglbjærg, C. S., Langdahl, B. L., Chapurlat, R., Czerwinski, E., Kendler, D. L., Reginster, J.-Y., Kivitz, A., Lewiecki, E. M., Miller, P. D., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1569 · Cited by 232
Self-citationLRP5 and LRP6 in development and disease
Joiner, D. M., Ke, J., Zhong, Z., Xu, H. E., & Williams, B. O. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.10.003 · Cited by 220
The Impact of Diabetes and Diabetes Medications on Bone Health
Gilbert, M. P., & Pratley, R. E. (2015) · Endocrine Reviews · doi:10.1210/er.2012-1042 · Cited by 209
Luukinen, H., Käkönen, S.-M., Pettersson, K., Koski, K., Laippala, P., Lövgren, T., Kivelä, S.-L., & Väänänen, H. K. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.12.2473 · Cited by 197
The Relation between Renal Function and Serum Sclerostin in Adult Patients with CKD
Pelletier, S., Dubourg, L., Carlier, M.-C., Hadj-Aissa, A., & Fouque, D. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07670712 · Cited by 196
Costa, L., Demers, L. M., Oliveira, A. G., Schaller, J. A., Costa, E. B., de Moura, M. C., & Lipton, A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.850 · Cited by 193
Determinants of bone strength and quality in diabetes mellitus in humans
Farr, J. N., & Khosla, S. (2016) · Bone · doi:10.1016/j.bone.2015.07.027 · Cited by 192
Delmas, P. D., Vrijens, B., Eastell, R., Roux, C., Pols, H. A. P., Ringe, J. D., Grauer, A., Cahall, D., Watts, N. B., & on behalf of the Improving Measurements of Persistence on Actonel Treatment (IMPACT) Investigators (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1526 · Cited by 186
Bone Loss in Men with Prostate Cancer Treated with Gonadotropin-Releasing Hormone Agonists1
Stoch, S. A., Parker, R. A., Chen, L., Bubley, G., Ko, Y.-J., Vincelette, A., & Greenspan, S. L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7558 · Cited by 186
A Meta-Analysis of Reference Markers of Bone Turnover for Prediction of Fracture
IFCC-IOF Joint Working Group on Standardisation of Biochemical Markers of Bone Turnover, Johansson, H., Odén, A., Kanis, J. A., McCloskey, E. V., Morris, H. A., Cooper, C., & Vasikaran, S. (2014) · Calcified Tissue International · doi:10.1007/s00223-014-9842-y · Cited by 184
Determinants of Bone Loss in Elderly Men and Women: A Prospective Population-Based Study
Dennison, E., Eastell, R., Fall, C. H. D., Kellingray, S., Wood, P. J., & Cooper, C. (1999) · Osteoporosis International · doi:10.1007/s001980050244 · Cited by 183
Type 2 diabetes mellitus and fracture risk
Dede, A. D., Tournis, S., Dontas, I., & Trovas, G. (2014) · Metabolism · doi:10.1016/j.metabol.2014.09.002 · Cited by 177
Rapid and robust response of biochemical markers of bone formation to teriparatide therapy
Glover, S. J., Eastell, R., McCloskey, E. V., Rogers, A., Garnero, P., Lowery, J., Belleli, R., Wright, T. M., & John, M. R. (2009) · Bone · doi:10.1016/j.bone.2009.07.091 · Cited by 176
Biochemical Markers as Predictors of Rates of Bone Loss After Menopause
Rogers, A., Hannon, R. A., & Professor Eastell, R. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.7.1398 · Cited by 172
Bone Resorption and Osteoporotic Fractures in Elderly Men: The Dubbo Osteoporosis Epidemiology Study
Meier, C., Nguyen, T. V., Center, J. R., Seibel, M. J., & Eisman, J. A. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041207 · Cited by 169
Ominsky, M. S., Niu, Q.-T., Li, C., Li, X., & Ke, H. Z. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2152 · Cited by 167
New developments in biological markers of bone metabolism in osteoporosis
Garnero, P. (2014) · Bone · doi:10.1016/j.bone.2014.05.016 · Cited by 160
Garnero, P., Sornay‐Rendu, E., Munoz, F., Borel, O., & Chapurlat, R. D. (2012) · Osteoporosis International · doi:10.1007/s00198-012-1978-x · Cited by 158
Long-term reduction in bone mass after severe burn injury in children
Klein, G. L., Herndon, D. N., Langman, C. B., Rutan, T. C., Young, W. E., Pembleton, G., Nusynowitz, M. L., Barnett, J. L., Broemeling, L. D., Sailer, D. E., et al. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70553-8 · Cited by 151
Biochemical Markers of Bone Turnover, Hip Bone Loss, and Fracture in Older Men: The MrOS Study
Bauer, D. C., Garnero, P., Harrison, S. L., Cauley, J. A., Eastell, R., Ensrud, K. E., & Orwoll, E. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090526 · Cited by 147
Bone Mineral Density and Serum Biochemical Predictors of Bone Loss in Patients with CKD on Dialysis
Malluche, H. H., Davenport, D. L., Cantor, T. L., & Monier‐Faugere, M. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09470913 · Cited by 146
Baim, S., & Miller, P. D. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090203 · Cited by 143
Porro, L. J., Herndon, D. N., Rodriguez, N. A., Jennings, K., Klein, G. L., Mlcak, R. P., Meyer, W. J., Lee, J. O., Suman, O. E., & Finnerty, C. C. (2012) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2011.12.038 · Cited by 143
Garnero, P., Cloos, P., Sornay-Rendu, E., Qvist, P., & Delmas, P. D. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.5.826 · Cited by 133
Development of an algorithm for using PINP to monitor treatment of patients with teriparatide
Eastell, R., Krege, J. H., Chen, P., Glass, E. V., & Reginster, J.-Y. (2006) · Current Medical Research and Opinion · doi:10.1185/030079905x75096 · Cited by 120
Self-citationSanz-Salvador, L., García‐Pérez, M. Á., Tarín, J. J., & Cano, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0424 · Cited by 119
Biver, E., Chopin, F., Coiffier, G., Funck‐Brentano, T., Bouvard, B., Garnero, P., & Cortet, B. (2011) · Joint Bone Spine · doi:10.1016/j.jbspin.2011.05.003 · Cited by 114
Klein, G. L., Herndon, D. N., Rutan, T. C., Sherrard, D. J., Coburn, J. W., Langman, C. B., Thomas, M. L., Haddad, J. G., Cooper, C. W., Miller, N. L., et al. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080311 · Cited by 113
Consensus on the utility of bone markers in the malignant bone disease setting
Coleman, R. E., Costa, L., Saad, F., Cook, R. J., Hadji, P., Terpos, E., Garnero, P., Brown, J. E., Body, J., Smith, M. R., et al. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.02.005 · Cited by 109
Self-citationChu, P., Chao, T.-Y., Lin, Y., Janckila, A. J., & Yam, L. T. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00203-8 · Cited by 107
Management of osteoporosis of the oldest old
Rizzoli, R., Branco, J., Brandi, M. L., Boonen, S., Bruyère, O., Cacoub, P., Cooper, C. C., Díez‐Pérez, A., Duder, J., Fielding, R. A., et al. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2755-9 · Cited by 104
Self-citationType 1 Diabetes and Osteoporosis: From Molecular Pathways to Bone Phenotype
Khan, T. S., & Fraser, L.-A. (2015) · Journal of Osteoporosis · doi:10.1155/2015/174186 · Cited by 94
Durosier, C., van Lierop, A., Ferrari, S., Chevalley, T., Papapoulos, S., & Rizzoli, R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2113 · Cited by 94
Self-citationSzulc, P., Montella, A., & Delmas, P. D. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.077941 · Cited by 92
Klein, G. L., Wimalawansa, S. J., Kulkarni, G. D., Sherrard, D. J., Sanford, A. P., & Herndon, D. N. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1731-1 · Cited by 89
Cavalier, E., Delanaye, P., Vranken, L. V., Bekaert, A.-C., Carlisi, A., Chapelle, J.-P., & Souberbielle, J. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr535 · Cited by 85
Self-citationEUROFORS Study Group, Blumsohn, A., Marin, F., Nickelsen, T., Brixen, K., Sigurdsson, G., González de la Vera, J., Boonen, S., Liu-Léage, S., Barker, C., et al. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1379-y · Cited by 80
Ardawi, M. S., Al-Sibiany, A., Bakhsh, T. M., Rouzi, A. A., & Qari, M. H. (2011) · Osteoporosis International · doi:10.1007/s00198-011-1806-8 · Cited by 75
Nioi, P., Taylor, S., Hu, R., Pacheco, E., He, Y. D., Hamadeh, H., Paszty, C., Pyrah, I., Ominsky, M. S., & Boyce, R. W. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2482 · Cited by 74
Fahrleitner, A., Prenner, G., Leb, G., Tscheliessnigg, K. H., Piswanger-Sölkner, C., Obermayer-Pietsch, B., Portugaller, H. R., Berghold, A., & Dobnig, H. (2003) · Bone · doi:10.1016/s8756-3282(02)00926-2 · Cited by 71 · cited 1×
“Using multiple regressions, OPG was found the only independent predictor of BMD changes ( R = 0.98; p < 0.001) [56]!”
MethodInfluentialAbildgaard, N., Brixen, K., Eriksen, E. F., Kristensen, J. E., Nielsen, J. L., & Heickendorff, L. (2004) · PubMed · Cited by 70
Ivaska, K. K., Lenora, J., Gerdhem, P., Åkesson, K., Väänänen, H. K., & Obrant, K. J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1508 · Cited by 69
von Tirpitz, C., Epp, S., Klaus, J., Mason, R., Hawa, G., Brinskelle-Schmal, N., Hofbauer, L. C., Adler, G., Kratzer, W., & Reinshagen, M. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200311000-00003 · Cited by 69 · cited 1×
“After 12 weeks, OC and OPG levels reached baseline values [55].”
BackgroundTargeting sclerostin as potential treatment of osteoporosis
Papapoulos, S. E. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.141150 · Cited by 69
Przkora, R., Herndon, D. N., Sherrard, D. J., Chinkes, D. L., & Klein, G. L. (2007) · Bone · doi:10.1016/j.bone.2007.04.195 · Cited by 68
Recent advances in the noninvasive diagnosis of renal osteodystrophy
Moorthi, R. N., & Moe, S. M. (2013) · Kidney International · doi:10.1038/ki.2013.254 · Cited by 68
Przkora, R., Herndon, D. N., Suman, O. E., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000219676.69331.fd · Cited by 64
When, How, and Why a Bone Biopsy Should Be Performed in Patients With Chronic Kidney Disease
Ureña, P., Bover, J., Mazzaferro, S., de Vernejoul, M. C., & Cohen-Solal, M. E. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.09.004 · Cited by 64
Biochemical Response to Treatment of Bone Hyperresorption in Chronically Critically Ill Patients
Nierman, D. M., & Mechanick, J. I. (2000) · CHEST Journal · doi:10.1378/chest.118.3.761 · Cited by 63
Delanaye, P., Souberbielle, J., Lafage‐Proust, M., Jean, G., & Cavalier, E. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft275 · Cited by 63
Self-citationThe role of bone turnover markers in monitoring treatment in postmenopausal osteoporosis
Szulc, P. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.01.022 · Cited by 62
Bone remodeling markers and bone metastases: From cancer research to clinical implications
Ferreira, A. R., Alho, I., Casimiro, S., & Costa, L. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.35 · Cited by 62
Diego, M., Lucas, A., de LIma, T., Milena, F.-S., Fernanda, P., & Gabriela, B. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu165.200 · Cited by 58
Pennypacker, B. L., Chen, C. M., Zheng, H., Shih, M., Belfast, M., Samadfam, R., & Duong, L. T. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2211 · Cited by 57
Farahmand, P., Marín, F., Hawkins, F. G., Moericke, R., Ringe, J. D., Glüer, C.-C., Παπαϊωάννου, Ν., Minisola, S., Martínez, G., Solé, J. M. N., et al. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2379-5 · Cited by 51
Schousboe, J. T., Bauer, D. C., Nyman, J. A., Kane, R. L., Melton, L. J., & Ensrud, K. E. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0218-7 · Cited by 49
Skeletal morbidity among survivors of critical illness*
Orford, N. R., Saunders, K., Merriman, E. N., Henry, M. J., Pasco, J. A., Stow, P. J., & Kotowicz, M. A. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318211ff3d · Cited by 48
Goemaere, S., Pottelbergh, I. V., Zmierczak, H., Toye, K. R. C., Daems, M., Demuynck, R., Myny, H., Bacquer, D. D., & Kaufman, J. (2001) · Bone · doi:10.1016/s8756-3282(01)00503-8 · Cited by 48
Self-citationGlucocorticoid-Induced Osteoporosis: Mechanisms and Therapeutic Approach
Devogelaer, J. (2006) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2006.09.001 · Cited by 45
Self-citationDenosumab for the management of bone disease in patients with solid tumors
Body, J. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.11.204 · Cited by 44
Self-citationBone turnover in patients with endogenous Cushing’s syndrome before and after successful treatment
Szappanos, Á., Tõke, J., Lippai, D., Patócs, A., Igaz, P., Szücs, N., Fütő, L., Gláz, E., Rácz, K., & Tóth, M. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0978-y · Cited by 43
Klein, G. L., Xie, Y., Qin, Y., et al. (2013) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-013-0483-4 · Cited by 41
The association between critical illness and changes in bone turnover in adults: a systematic review
Orford, N. R., Cattigan, C., Brennan-Olsen, S. L., Kotowicz, M. A., Pasco, J. A., & Cooper, D. J. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2734-1 · Cited by 40
Som, A., Tu, S.-M., Liu, J., Wang, X., Qiao, W., Logothetis, C. J., & Corn, P. G. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.436 · Cited by 36
Future directions for new medical entities in osteoporosis
Ferrari, S. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.08.002 · Cited by 34
Self-citationBiomarkers of Bone Turnover after a Short Period of Steroid Therapy in Elderly Men
Paglia, F., Dionisi, S., Geronimo, S. D., Rosso, R., Romagnoli, E., Raejentroph, N., Ragno, A., Celi, M., Pepe, J., D'Erasmo, E., et al. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.7.1314 · Cited by 32
Current and future treatments of osteoporosis in men
Kaufman, J., Lapauw, B., & Goemaere, S. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.09.002 · Cited by 30
Self-citationCritical care and vitamin D status assessment: What about immunoassays and calculated free 25OH-D?
Rousseau, A., Damas, P., Janssens, M., Kalin, S., Ledoux, D., Goff, C. M. L., Gadisseur, R., Delanaye, P., & Cavalier, E. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.07.007 · Cited by 29
Self-citationCathepsin K Preferentially Solubilizes Matured Bone Matrix
Borel, O., Gineyts, É., Bertholon, C., & Garnero, P. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9604-7 · Cited by 29
Monitoring of osteoporosis therapy
Bruyère, O., & Reginster, J. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.07.001 · Cited by 27
Self-citationBiochemical Bone Turnover Markers and Osteoporosis in Older Men: Where Are We?
Szulc, P. (2011) · Journal of Osteoporosis · doi:10.4061/2011/704015 · Cited by 26
Bone Mineral Density After Burn Injury and Its Relation to the Characteristics of Scar Tissue
Terzi, R., & Güven, M. (2015) · Journal of Burn Care & Research · doi:10.1097/bcr.0000000000000241 · Cited by 22
Devogelaer, J.-P., Sambrook, P., Reid, D. M., Goemaere, S., Ish-Shalom, S., Collette, J., Su, G., Bucci-Rechtweg, C., Papanastasiou, P., & Reginster, J.-Y. (2013) · Rheumatology · doi:10.1093/rheumatology/kes410 · Cited by 19 · cited 2×
“All BPs suppress the excessive turnover, proportionally to their potency [50, 57].”
BackgroundResultSelf-citationKaji, H., Kuroki, Y., Murakawa, Y., Funakawa, I., Funasaka, Y., Kanda, F., & Sugimoto, T. (2010) · Osteoporosis International · doi:10.1007/s00198-009-1110-z · Cited by 16
Tartrate-resistant acid phosphatase as a serum marker of bone resorption.
Halleen, J. M., & Ranta, R. E. (2001) · PubMed · Cited by 16
Honjo, S., & Mizunuma, H. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.113910 · Cited by 15
Darelid, A., Nilsson, M., Kindblom, J. M., Mellström, D., Ohlsson, C., & Lorentzon, M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3947 · Cited by 14
Gielen, E., O’Neill, T. W., Pye, S. R., Adams, J. E., Ward, K. A., Wu, F. C. W., Laurent, M. R., Claessens, F., Boonen, S., Vanderschueren, D., et al. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2884-1 · Cited by 13
Self-citationThe Effects of Strontium Ranelate in Asian Women with Postmenopausal Osteoporosis
Hwang, J., Chen, J. F., Yang, T., et al. (2009) · Calcified Tissue International · doi:10.1007/s00223-009-9233-y · Cited by 1
Cited by
The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms
Al-Bashaireh, A. M., Haddad, L. G., Weaver, M., Chengguo, X., Kelly, D. L., & Yoon, S. (2018) · Journal of Osteoporosis · doi:10.1155/2018/1206235 · Cited by 209
Crawford, M. R., Pham, N. N., Khan, L. A., Bena, J. F., Schauer, P. R., & Kashyap, S. R. (2018) · Endocrine Practice · doi:10.4158/ep-2017-0072 · Cited by 54
Metadata
- Authors
- Cavalier, E., Bergmann, P., Bruyère, O., Delanaye, P., Durnez, A., Devogelaer, J.-P., Ferrari, S. L., Gielen, E., Goemaere, S., Kaufman, J.-M., Toukap, A. N., Reginster, J.-Y., Rousseau, A.-F., Rozenberg, S., Scheen, A. J., & Body, J.-J.
- Affiliations
- University of Liège (BE)
- Université Libre de Bruxelles (BE)
- Cliniques Universitaires Saint-Luc (BE)
- University Hospital of Geneva (CH)
- KU Leuven (BE)
- Ghent University Hospital (BE)
- Corresponding author
- Cavalier, E.
- ORCID
- Venue
- Osteoporosis International
- Published
- 2016-03-30
- Volume
- 27
- Issue
- 7
- Pages
- 2181-2195
- ISSN
- 0937-941X (ISSN-L)
- 1433-2965
- OpenAlex
- W2322573421
- Cited by
- 63
- References
- 106
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 7 · 2020: 3 · 2019: 5 · 2018: 9 · 2017: 11 · 2016: 4
- FWCI
- 11.76
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by
- www.springer.com/tdm (tdm)
- Locations
- Osteoporosis International (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Digital Access to Libraries (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Lirias (KU Leuven) (submittedVersion)
- Open Repository and Bibliography (University of Liège) (submittedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- bone turnover markers, osteoporosis, metabolic bone disease, postmenopausal women, male osteoporosis, elderly patients, bone metastasis, chronic kidney disease, pregnancy and lactation, intensive care, diabetes mellitus, emerging biomarkers
- MeSH terms
- Belgium, Bone Diseases, Metabolic, Bone Neoplasms, Female, Humans, Lactation, Male, Osteoporosis, Pregnancy, Biomarkers, Bone Density, Osteoporosis, Postmenopausal, Bone Remodeling, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.